Caribou Biosciences, Inc. (CRBU)

Caribou Biosciences Stock Forecast

Stock Price Forecast

According to 4 professional analysts, the 12-month price target for Caribou Biosciences stock ranges from a low of $3.00 to a high of $14. The average analyst price target of $8.50 forecasts a 574.60% increase in the stock price over the next year.

Price Target: $8.50 (+574.60%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$3.00	$8.50	$11	$14
Change	+138.10%	+574.60%	+773.02%	+1011.1%

* Price targets were last updated on Apr 28, 2025.

Analyst Ratings

The average analyst rating for Caribou Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	4	4	4	4	4	3
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	5	5	5	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $9 → $3	Strong Buy	Maintains	$9 → $3	+138.10%	Apr 28, 2025
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $9	Strong Buy	Reiterates	$9	+614.29%	Mar 19, 2025
Alec Stranahan B of A Securities	B of A Securities	Strong Buy Maintains $13 → $11	Strong Buy	Maintains	$13 → $11	+773.02%	Jan 7, 2025
Yigal Nochomovitz Citigroup	Citigroup	Strong Buy Maintains $30 → $6	Strong Buy	Maintains	$30 → $6	+376.19%	Nov 26, 2024
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $9	Strong Buy	Reiterates	$9	+614.29%	Nov 15, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

11.28M

Increased by 12.83%

from 9.99M

Revenue Next Year

10.60M

Decreased by -6.03%

from 11.28M

EPS This Year

-1.45

from -1.65

EPS Next Year

-1.19

from -1.45

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	12.36M	9.60M	13.85M	34.48M	9.99M	11.28M	10.60M	12.19M
Revenue Growth	113.56%	-22.35%	44.31%	148.91%	-71.01%	12.83%	-6.03%	15.03%
EPS	-4.01	-2.11	-1.64	-1.38	-1.65	-1.45	-1.19	-1.01
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	11	9	7

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	14.7M	12.1M	15.8M
Avg	11.3M	10.6M	12.2M
Low	9.7M	9.7M	9.7M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	47.1%	7.1%	48.6%
Avg	12.8%	-6.0%	15.0%
Low	-2.5%	-13.6%	-8.1%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-0.86	-0.53	0.03
Avg	-1.45	-1.19	-1.01
Low	-1.85	-1.68	-1.76

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.